Related Experiment Video
Updated: Dec 26, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway
Ke Tian1, Wanggen Liu2, Jing Zhang3
11Department of Dermatology, Affiliated Hospital of Hebei University of Engineering, Handan, 056002 China.
Background:
MicroRNA-125b (miR-125b) is downregulated in human cutaneous squamous cell carcinoma (CSCC). However, its function in CSCC has yet to be extensively explored. Here, we analyze the relationship between signal transducer and activator of transcription 3 (STAT3) and miR-125b in CSCC.
Methods:
Western blotting and quantitative RT-PCR were used to determine the expression of the miR-125b-STAT3 axis in human CSCC tissues and cell lines. The direct regulatory effect of miR-125b on STAT3 expression was assessed using a luciferase reporter gene assay and RNA immunoprecipitation assay. The MTT assay and flow cytometry were used to determine the role of the miR-125b-STAT3 axis in CSCC cell proliferation and apoptosis.
Results:
MiR-125b expression levels were significantly lower in CSCC cell lines and tissues than in normal cell lines and tissues. STAT3 was identified as the direct target of miR-125b. Upregulation of miR-125b and downregulation of STAT3 suppressed cell proliferation and promoted cell apoptosis. Cyclin D1 and Bcl2 were identified as the downstream targets of the miR-125-STAT3 axis.
Conclusions:
Our findings indicate that miR-125b acts as a tumor suppressor in CSCC by targeting the STAT3 pathway. This observation increases our understanding of the molecular mechanisms of CSCC. Therapies aimed at activating miR-125b or inhibiting STAT3 signaling should be explored as potential treatments for CSCC.
Insights
MicroRNA-125b (miR-125b) suppresses cutaneous squamous cell carcinoma (CSCC) by targeting the STAT3 pathway. Restoring miR-125b levels may offer a novel therapeutic strategy for CSCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNA-125b (miR-125b) is downregulated in human cutaneous squamous cell carcinoma (CSCC).
- The precise function of miR-125b in CSCC pathogenesis remains incompletely understood.
- The interaction between miR-125b and signal transducer and activator of transcription 3 (STAT3) in CSCC requires further investigation.
Purpose of the Study:
- To elucidate the functional role of miR-125b in CSCC.
- To investigate the regulatory relationship between miR-125b and STAT3 in CSCC.
- To determine the impact of the miR-125b-STAT3 axis on CSCC cell behavior.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blotting to assess expression levels of the miR-125b-STAT3 axis.
- Luciferase reporter gene assays and RNA immunoprecipitation (RIP) to confirm direct targeting of STAT3 by miR-125b.
- MTT assays and flow cytometry to evaluate the effects of modulating the miR-125b-STAT3 axis on CSCC cell proliferation and apoptosis.
Main Results:
- Significantly lower miR-125b expression and higher STAT3 expression were observed in CSCC tissues and cell lines compared to normal controls.
- miR-125b was confirmed to directly target and downregulate STAT3 expression.
- Overexpression of miR-125b suppressed CSCC cell proliferation and induced apoptosis, partly through the downregulation of STAT3, Cyclin D1, and Bcl2.
Conclusions:
- miR-125b functions as a tumor suppressor in CSCC by inhibiting the STAT3 signaling pathway.
- The miR-125b-STAT3 axis represents a critical molecular mechanism in CSCC development.
- Targeting miR-125b activation or STAT3 inhibition presents a promising therapeutic avenue for CSCC.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

